BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 94 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $755,000 | +273.8% | 13,348 | +275.4% | 0.00% | – |
Q4 2019 | $202,000 | -14.4% | 3,556 | -19.6% | 0.00% | – |
Q3 2019 | $236,000 | -95.3% | 4,422 | -94.8% | 0.00% | -100.0% |
Q2 2019 | $5,048,000 | +319.6% | 84,537 | +338.0% | 0.01% | +300.0% |
Q1 2019 | $1,203,000 | -5.4% | 19,300 | -8.0% | 0.00% | 0.0% |
Q4 2018 | $1,272,000 | -19.5% | 20,989 | -40.4% | 0.00% | 0.0% |
Q2 2018 | $1,580,000 | +44.8% | 35,212 | +43.1% | 0.00% | +100.0% |
Q1 2018 | $1,091,000 | +58.1% | 24,611 | +54.7% | 0.00% | 0.0% |
Q4 2017 | $690,000 | +74.2% | 15,913 | +86.8% | 0.00% | 0.0% |
Q3 2017 | $396,000 | +93.2% | 8,517 | +105.7% | 0.00% | – |
Q2 2017 | $205,000 | -70.0% | 4,140 | -78.9% | 0.00% | -100.0% |
Q1 2016 | $683,000 | +187.0% | 19,610 | +254.2% | 0.00% | +100.0% |
Q4 2015 | $238,000 | -54.7% | 5,537 | -58.7% | 0.00% | 0.0% |
Q1 2015 | $525,000 | +69.4% | 13,400 | +66.9% | 0.00% | 0.0% |
Q4 2014 | $310,000 | +11.9% | 8,031 | -21.8% | 0.00% | 0.0% |
Q2 2014 | $277,000 | – | 10,265 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |